TrialStem cell reports2026

Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials.

Shane W English et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.